Publications by authors named "Greg Dueck"

Claim this Profile
O
Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.
Bruce D Cheson, Neil Chua, Jiri Mayer, Greg Dueck, Marek Trněný

J Clin Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma.
Ethan Toumishey, Angeli Prasad, Greg Dueck, Neil Chua, Daygen Finch

Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma.
Robert P Evans, Greg Dueck, Roger Sidhu, Sunita Ghosh, Inka Toman

Leuk Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma.
Greg Dueck, Neil Chua, Angeli Prasad, Daygen Finch, Doug Stewart

Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis